IESE (España)
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Terra Lycos
Perry, Gaynor; Oliver C.; Valor Sabatier, Josep; Sieber, SandraCase SI-130-EInformation Technologies, Knowledge and CommunicationIn May 2000, the leading Spanish language portal and Internet Access Provider (IAP), Terra, announced that they were to buy the fourth ranking US portal, Lycos, for $12.5 billion in stock. This merger enabled Terra to expand from Spanish and Portugese speaking markets to become a global player. However, the continued success of the big three portals, AOL, MSN and Yahoo!, has kept Terra Lycos amongst the second tier of portal companies. Against a ...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Terra Lycos
Perry, Gaynor; Oliver C.; Valor Sabatier, Josep; Sieber, SandraCase SI-130Information Technologies, Knowledge and CommunicationEn mayo de 2000, el portal y proveedor de acceso a Internet (IAP) líder en lengua castellana, Terra, anunció que iba a comprar el portal situado en cuarta posición en Estados Unidos, Lycos, por una cifra de 125 millardos de dólares abonada mediante intercambio de acciones. Esta fusión permitió a Terra expandirse más allá de sus mercados de habla española y portuguesa, convirtiéndose así en un actor global. No obstante, el éxito continuado de los ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Terra Lycos (Portuguese Version, Brazil)
Perry, Gaynor; Oliver C.; Valor Sabatier, Josep; Sieber, SandraCase SI-130-PBInformation Technologies, Knowledge and CommunicationIn May 2000, the leading Spanish language portal and Internet Access Provider (IAP), Terra, announced that they were to buy the fourth ranking US portal, Lycos, for $12.5 billion in stock. This merger enabled Terra to expand from Spanish and Portugese speaking markets to become a global player. However, the continued success of the big three portals, AOL, MSN and Yahoo!, has kept Terra Lycos amongst the second tier of portal companies. Against a ...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20